大家都搜：
膜抗原
1、cricothyroid membrane───[医]环甲膜
2、arachnoid membrane───蛛网膜
3、dialyzing membrane───透析膜；渗析膜
4、filtration membrane───滤过膜；滤膜
5、eggshell membrane───蛋壳膜
6、membrane───n.膜；薄膜；羊皮纸
7、membrane definition───膜的定义
8、amniotic membrane───羊膜
9、membrane protein───膜蛋白质
1、An immunohistochemical study of prostatic carcinoma with the use of monoclonal antibody against prostate specific membrane antigen───抗前列腺特异膜抗原单克隆抗体的前列腺癌免疫病理研究
2、Clinical significance of a new alternatively spliced variant of prostate specific membrane antigen───新型前列腺特异膜抗原剪接变异体的发现及临床意义初步探讨
3、The Construction of Recombinant Plasmid with Prostate-specific Membrane Antigen Promoter Controlling Reporter Gene Expression───前列腺特异性膜抗原启动子调控的重组质粒的构建及表达
4、Objective to establish DIGFA to examine HRA absorbed by membrane antigen of a group hemolytic streptococcus and study the value for diagnosis of rheumatic heart disease using this method.───目的建立金标免疫渗滤法(DIGFA)检测A组溶血性链球菌膜抗原吸附心肌抗体(HRA)，探讨其对风湿性心脏病诊断的意义。
5、Immunogold labelling technique was used for in situ ultrastructural detection of antibodies 51KD human sperm membrane antigen.───本文应用免疫金标记法，对抗51KDJingZi膜抗原的抗JingZi抗体在JingZi的定位进行了超微结构观察。
6、Cells in the cell membrane there are many different signs, mainly on the surface and surface antigen receptor.───细胞的细胞膜上有许多不同的标志，主要是表面抗原和表面受体。
7、Research Progress on the surface membrane antigen molecules of schistosoma───血吸虫表膜抗原分子的研究进展
8、Prostate-specific membrane antigen(PSMA), the research of which has flourished in recent years, is a specific prostate cancer marker.───近年来，前列腺癌特异性的分子标志物——前列腺特异性膜抗原 (P S M A)已成为前列腺癌临床研究中的热点之一。
9、CONCLUSION: the positive circulating membrane antigen reaction is closely related to egg laying by the female worms.───结论：循环表膜抗原阳性反应与雌虫排卵密切相关。
1、The distribution of the epithelial membrane antigen (EMA) of cervical smear cells in 67 patients has been examined with microwave immunohistochemical ABC technique.
2、The spindle cells were immunopositive for actins and vimentin, and negative for keratins, epithelial membrane antigen, desmin, and S-100 protein.
3、The Phase I clinical trial tested an antibody called J591, targeted to the prostate specific membrane antigen (PSMA).